Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention

Ronald B. Goldberg, Marinella Temprosa, Steven Haffner, Trevor J. Orchard, Robert E. Ratner, Sarah E. Fowler, Kieren Mather, Santica Marcovina, Chris Saudek, Margaret J. Matulik, David Price

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

OBJECTIVE - Although subjects with diabetes have increased risk for cardiovascular disease (CVD), the evolution of this increased risk as pre-diabetic individuals progress to diabetes is not understood. This study examines the longitudinal relationship between selected CVD risk factors (blood pressure, triglycerides, HDL and LDL cholesterol, and LDL peak particle density [PPD]) and glycemia in the three treatment groups of the Diabetes Prevention Program. RESEARCH DESIGN AND METHODS - A total of 3,234 participants with impaired glucose tolerance (IGT) were followed for a mean of 3.2 years after randomization to intensive lifestyle intervention (ILS), metformin, or placebo. Using repeated-measures models, adjusted mean levels of risk factors were estimated for an annual change in glycemic status. Tests were also conducted to assess the risk factor trends with improvement or worsening of glycemic status. RESULTS - CVD risk factor values and changes from baseline became more unfavorable as glucose tolerance status deteriorated but improved with reversion to normal glucose tolerance (NGT), especially in the ILS intervention group (trend test P <0.001 for all risk factors except for LDL PPD [P = 0.02] in ILS and HDL cholesterol [P = 0.02] in placebo). Although there were few significant differences in the transition from IGT to diabetes, there were strong relationships between risk factors and continuous measures of glycemia. CONCLUSIONS - Progression from IGT to diabetes is associated with mild deterioration, whereas reversion to NGT is associated with improvement in risk factors. Early intervention with ILS, but less so with metformin, in participants at high risk for diabetes improves the cardiovascular risk and glucose tolerance profile simultaneously.

Original languageEnglish (US)
Pages (from-to)726-732
Number of pages7
JournalDiabetes Care
Volume32
Issue number4
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Glucose Intolerance
Metformin
Life Style
Glucose
Cardiovascular Diseases
HDL Cholesterol
Placebos
Random Allocation
LDL Cholesterol
Longitudinal Studies
Triglycerides
Research Design
Blood Pressure

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention. / Goldberg, Ronald B.; Temprosa, Marinella; Haffner, Steven; Orchard, Trevor J.; Ratner, Robert E.; Fowler, Sarah E.; Mather, Kieren; Marcovina, Santica; Saudek, Chris; Matulik, Margaret J.; Price, David.

In: Diabetes Care, Vol. 32, No. 4, 04.2009, p. 726-732.

Research output: Contribution to journalArticle

Goldberg, RB, Temprosa, M, Haffner, S, Orchard, TJ, Ratner, RE, Fowler, SE, Mather, K, Marcovina, S, Saudek, C, Matulik, MJ & Price, D 2009, 'Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention', Diabetes Care, vol. 32, no. 4, pp. 726-732. https://doi.org/10.2337/dc08-0494
Goldberg, Ronald B. ; Temprosa, Marinella ; Haffner, Steven ; Orchard, Trevor J. ; Ratner, Robert E. ; Fowler, Sarah E. ; Mather, Kieren ; Marcovina, Santica ; Saudek, Chris ; Matulik, Margaret J. ; Price, David. / Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention. In: Diabetes Care. 2009 ; Vol. 32, No. 4. pp. 726-732.
@article{1a7614ba2d584b00a92a25a63fa13e5d,
title = "Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention",
abstract = "OBJECTIVE - Although subjects with diabetes have increased risk for cardiovascular disease (CVD), the evolution of this increased risk as pre-diabetic individuals progress to diabetes is not understood. This study examines the longitudinal relationship between selected CVD risk factors (blood pressure, triglycerides, HDL and LDL cholesterol, and LDL peak particle density [PPD]) and glycemia in the three treatment groups of the Diabetes Prevention Program. RESEARCH DESIGN AND METHODS - A total of 3,234 participants with impaired glucose tolerance (IGT) were followed for a mean of 3.2 years after randomization to intensive lifestyle intervention (ILS), metformin, or placebo. Using repeated-measures models, adjusted mean levels of risk factors were estimated for an annual change in glycemic status. Tests were also conducted to assess the risk factor trends with improvement or worsening of glycemic status. RESULTS - CVD risk factor values and changes from baseline became more unfavorable as glucose tolerance status deteriorated but improved with reversion to normal glucose tolerance (NGT), especially in the ILS intervention group (trend test P <0.001 for all risk factors except for LDL PPD [P = 0.02] in ILS and HDL cholesterol [P = 0.02] in placebo). Although there were few significant differences in the transition from IGT to diabetes, there were strong relationships between risk factors and continuous measures of glycemia. CONCLUSIONS - Progression from IGT to diabetes is associated with mild deterioration, whereas reversion to NGT is associated with improvement in risk factors. Early intervention with ILS, but less so with metformin, in participants at high risk for diabetes improves the cardiovascular risk and glucose tolerance profile simultaneously.",
author = "Goldberg, {Ronald B.} and Marinella Temprosa and Steven Haffner and Orchard, {Trevor J.} and Ratner, {Robert E.} and Fowler, {Sarah E.} and Kieren Mather and Santica Marcovina and Chris Saudek and Matulik, {Margaret J.} and David Price",
year = "2009",
month = "4",
doi = "10.2337/dc08-0494",
language = "English (US)",
volume = "32",
pages = "726--732",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention

AU - Goldberg, Ronald B.

AU - Temprosa, Marinella

AU - Haffner, Steven

AU - Orchard, Trevor J.

AU - Ratner, Robert E.

AU - Fowler, Sarah E.

AU - Mather, Kieren

AU - Marcovina, Santica

AU - Saudek, Chris

AU - Matulik, Margaret J.

AU - Price, David

PY - 2009/4

Y1 - 2009/4

N2 - OBJECTIVE - Although subjects with diabetes have increased risk for cardiovascular disease (CVD), the evolution of this increased risk as pre-diabetic individuals progress to diabetes is not understood. This study examines the longitudinal relationship between selected CVD risk factors (blood pressure, triglycerides, HDL and LDL cholesterol, and LDL peak particle density [PPD]) and glycemia in the three treatment groups of the Diabetes Prevention Program. RESEARCH DESIGN AND METHODS - A total of 3,234 participants with impaired glucose tolerance (IGT) were followed for a mean of 3.2 years after randomization to intensive lifestyle intervention (ILS), metformin, or placebo. Using repeated-measures models, adjusted mean levels of risk factors were estimated for an annual change in glycemic status. Tests were also conducted to assess the risk factor trends with improvement or worsening of glycemic status. RESULTS - CVD risk factor values and changes from baseline became more unfavorable as glucose tolerance status deteriorated but improved with reversion to normal glucose tolerance (NGT), especially in the ILS intervention group (trend test P <0.001 for all risk factors except for LDL PPD [P = 0.02] in ILS and HDL cholesterol [P = 0.02] in placebo). Although there were few significant differences in the transition from IGT to diabetes, there were strong relationships between risk factors and continuous measures of glycemia. CONCLUSIONS - Progression from IGT to diabetes is associated with mild deterioration, whereas reversion to NGT is associated with improvement in risk factors. Early intervention with ILS, but less so with metformin, in participants at high risk for diabetes improves the cardiovascular risk and glucose tolerance profile simultaneously.

AB - OBJECTIVE - Although subjects with diabetes have increased risk for cardiovascular disease (CVD), the evolution of this increased risk as pre-diabetic individuals progress to diabetes is not understood. This study examines the longitudinal relationship between selected CVD risk factors (blood pressure, triglycerides, HDL and LDL cholesterol, and LDL peak particle density [PPD]) and glycemia in the three treatment groups of the Diabetes Prevention Program. RESEARCH DESIGN AND METHODS - A total of 3,234 participants with impaired glucose tolerance (IGT) were followed for a mean of 3.2 years after randomization to intensive lifestyle intervention (ILS), metformin, or placebo. Using repeated-measures models, adjusted mean levels of risk factors were estimated for an annual change in glycemic status. Tests were also conducted to assess the risk factor trends with improvement or worsening of glycemic status. RESULTS - CVD risk factor values and changes from baseline became more unfavorable as glucose tolerance status deteriorated but improved with reversion to normal glucose tolerance (NGT), especially in the ILS intervention group (trend test P <0.001 for all risk factors except for LDL PPD [P = 0.02] in ILS and HDL cholesterol [P = 0.02] in placebo). Although there were few significant differences in the transition from IGT to diabetes, there were strong relationships between risk factors and continuous measures of glycemia. CONCLUSIONS - Progression from IGT to diabetes is associated with mild deterioration, whereas reversion to NGT is associated with improvement in risk factors. Early intervention with ILS, but less so with metformin, in participants at high risk for diabetes improves the cardiovascular risk and glucose tolerance profile simultaneously.

UR - http://www.scopus.com/inward/record.url?scp=65349089411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349089411&partnerID=8YFLogxK

U2 - 10.2337/dc08-0494

DO - 10.2337/dc08-0494

M3 - Article

VL - 32

SP - 726

EP - 732

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 4

ER -